möglich sobald bei der ZB eingereicht worden ist.
Monitoring of diabetic late complication.
In: Drug Discovery and Evaluation: Pharmacological Assays. Cham, Switzerland: Springer, 2016. 3071-3117
Secondary symptoms of long-lasting diabetes mellitus are diabetic neuropathy with sensory symptoms, motoric disturbances due to reduced nerve conduction velocity, and diabetic cataracts. Both are related to enhanced conversion of glucose to polyols, such as sorbitol, by the enzyme aldose reductase (van Heyningen 1959; Clements 1979). Sorbitol is converted to fructose by sorbitol dehydrogenase. A low activity of this enzyme enhances the accumulation of sorbitol, thus contributing to cellular damage. Inhibitors of aldose reductase have been developed with positive results in diabetic patients (Kador et al. 1985).
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Sammelbandbeitrag/Buchkapitel
Herausgeber
Hock, F.J.*
e-ISSN
978-3-319-05392-9
ISBN
978-3-319-05391-2
Bandtitel
Drug Discovery and Evaluation: Pharmacological Assays
Quellenangaben
Seiten: 3071-3117
Verlag
Springer
Verlagsort
Cham, Switzerland
Nichtpatentliteratur
Publikationen
Institut(e)
Institute of Diabetes and Obesity (IDO)